Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

172.23
BATS BZX Real-Time Price
As of 3:55pm ET
 +3.66 / +2.17%
Today’s Change
150.06
Today|||52-Week Range
203.30
-6.92%
Year-to-Date

Today’s Trading

Previous close168.57
Today’s open167.69
Day’s range167.31 - 172.65
Volume2,152,350
Average volume (3 months)1,718,368
Market cap$33.6B
Dividend yield--
Data as of 3:40pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+1.57%
Earnings growth (next 5 years)+21.56%
Revenue growth (last year)+46.49%
P/E ratio58.9
Price/Sales16.55
Price/Book10.16

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.31-0.44%
VRTXVertex Pharmaceutica...+0.21+0.17%
PRGOPerrigo Company PLC+0.36+0.18%
ZTSZoetis Inc-0.15-0.31%
Data as of 3:55pm ET, 05/22/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$1.39
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers